4 particles for transduction of U937 cells. sgRNAs used were: TTATCTTCAAGCCACTCCAG (DCK), ACAGCAGAGATGTCAAGCAG (ADK), and TGAACTGAGCAAGGACGCCC (SLC29A1). For simultaneous deletion of ADK and DCK, lentiCRISPR v2 plasmids containing ADK and DCK targeting sgRNAs were co-transduced into U937 cells. Following transduction, cells were selected with puromycin (2.5 µg/ml) for 7 days to complete gene editing. Single cells were isolated, and clonally expanded and genomic DNA was isolated with the DNeasy Blood & Tissue Kit (Quiagen, Hilden, Germany). Genomic regions targeted by the corresponding sgRNA and Cas9 were amplified by polymerase chain reaction (PCR) with primers listed in Supplementary Table S4 , and cloned via the Zero Blunt™ TOPO™ PCR Cloning Kit (Thermo Fisher). Candidate plasmids from various E. coli clones were subjected to sequencing to confirm bi-allelic gene disruptions.
Next generation sequencing (NGS), Sanger sequencing and bioinformatics. DNA
samples obtained from the CRISPR-Cas9 GeCKO screen were used to prepare a sgRNA library with a two-step PCR protocol (1, 2) . The first PCR was used to amplify the sgRNA containing cassette. Amplified products were subjected to a second PCR with a primer pair encoding a unique 8-bp barcode required for multiplexing along with a stagger sequence to increase library complexity, as described [http://genome-engineering.org/gecko; (1, 2)]. Products of the second PCR were purified, pooled, diluted and mixed with 10% PhiX, and sequenced with HiSeq2500 (Illumina).
The raw sequencing data were processed and analyzed using customized CRI CRISPRCas9 library screen pipelines. Briefly, sequencing reads were first de-multiplexed by using the barcode in the reverse primer, and processed by Cutadapt (3) to remove sequences from beginning to sgRNA priming site primers. Trimmed reads were used to map sgRNA sequences to pooled GeCKO v2 libraries A and B. Read counts of sgRNA for each sample were quantified by MAGeCK v5.6.0 (4). Count data were filtered and normalized, and essential sgRNA and genes were ranked by MAGeCK (4).
DNA samples obtained from the CRISPR-Cas9 GeCKO screen were also used to analyze the distribution of individual sgRNAs via Sanger sequencing. Here, the sgRNA cassette was PCRamplified from the dAdo-resistant U937 cell population, and cloned via the Zero Blunt™ TOPO™ PCR Cloning Kit (Thermo Fisher). 80 independent E. coli-derived plasmids containing the sgRNA cassette were sequenced, and used to identify genes targeted by the individual sgRNA. All sgRNA sequences recovered were mapped to pooled GeCKO v2 libraries A and B.
Immunoblotting. U937 cells were washed twice in ice-cold 1  PBS, and lysed for 30 min in ice-cold lysis buffer (1  PBS and 0.5 % Triton X-100) containing the protease inhibitor cocktail from Pierce. During this procedure, cells were sonicated 6 times (5 seconds pulse each) by using an ultrasonicator instrument. Cell lysates were centrifuged for 10 min at 15,000 g and 4°C. aureus Newman or mutant strains were grown overnight in TSB, diluted 1:100 in RPMI 1640 medium, and grown at 37°C to 5.0  10 7 colony forming units (CFU)/ml. Next, 6.0 x 10 7 CFU were incubated in RPMI 1640 containing 28 µg/ml Thymus DNA (Sigma) for 3 h at 37°C. Controls were equally processed, and lacked bacteria or DNA, or included S. aureus mutants that cannot generate dAdo precursors (nuc) or cannot produce dAdo (adsA). Bacteria were removed by centrifugation, culture supernatants filter-sterilized and incubated with 2.0  10 5 U937 wildtype or mutant cell lines per well, or with 4.0  10 5 U937-derived macrophages (24-well plate) in the presence of 50 µM dCF. Cells were incubated for 24 h at 37°C under 5% CO2, and killing efficiency was quantified with Trypan Blue staining.
Analysis of caspase-3 activity. Caspase-3 activity was determined using the colorimetric caspase-3 detection kit (Sigma). Briefly, wild-type and mutant U937 cells were incubated for 24 h at 37°C under 5% CO2 with dCF (50 µM) and dAdo (5 and 10 µM for U937 cells and U937-derived macrophages, respectively). Cells (1.0  10 7 ) were washed once in PBS and lysed on ice for 20 min in lysis buffer (Sigma kit). Lysates were centrifuged (18,000 g for 10 min at 4°C) and supernatants incubated with acetyl-DEVD-pNA, a substrate of caspase-3. The capase-3 inhibitor Ac-DEVD-CHO was used in control experiments (Sigma kit). Caspase-3 activity was measured in μmol of pNA released per min per ml of cell lysate.
Deoxyadenosine uptake studies. Uptake of deoxyadenosine into U937 cells was performed as described previously with minor modifications (6) . Briefly, 1.5  10 6 U937 cells were suspended in 400 µl growth medium and seeded into 24-well plates. 1 µCi CO2. Cells were washed twice with cold PBS, and treated with 500 µl ice-cold 60% methanol to extract cellular nucleosides and nucleotides (7). Samples were vigorously vortexed for 20 sec and incubated at 95°C for 3 min. Aliquots (25 µl) were removed to determine the protein concentration via the BCA method. The remaining sample was centrifuged to remove cell debris and insoluble material for 5 min at 16,000 g. Supernatants containing soluble nucleosides and nucleotides were removed, dried, suspended in 15 µl deionized water and applied (3 µl) to TLC plates (SIL G, Macherey-Nagel). The migratory positions of dAdo, dAMP, AMP, dADP and dATP were identified with non-radiolabeled standards that were visualized under UV light at 254 nm.
TLC sheets were developed in the ascending direction at room temperature by using a water/isopropanol/ammonium bicarbonate mixture (25%:75%:0.2 M). Chromatograms were developed by autoradiography. Individual dATP, dADP, and dAMP spots were excised from TLC plates and radioactivity quantified by LSC.
Sequencing chromatograms and statistical analysis. Sequencing chromatograms were generated with DNASTAR (DNASTAR software, Inc., Madison WI, USA, Version 12.0.0). Statistical analysis was performed with GraphPad Prism (GraphPad Software, Inc., La Jolla USA, Version 9 5.04). Statistically significant differences were calculated by using statistical methods as indicated. P values ≤ 0.05 were considered significant. determinations. Statistical analyses were performed by one-way ANOVA with Bonferroni's multiple comparison test; ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
